TesTBI is an electrochemical test to be used for detection of Traumatic Brain Injuries from urine samples. In the current campaign, Medicortex aims to raise up to 100,000€ to fund the first developmental phase of TesTBI. The fundraising campaign runs between 14 and 28 of November 2023.
Shares can be subscribed by filling in, printing, and signing the document above, after which the (scanned) document can be sent via email: medicortexmedicortex.fi or mail: Medicortex Finland Oyj, Itäinen Pitkäkatu 4 B, 4th floor, FI-20520 Turku, Finland. We will return you a copy of the agreement signed by the representative of the company, after which you have 14 days to pay the total subscription price to the Nordea bank account provided on the last page of the subscription agreement. Company’s Board of Directors will confirm the subscriptions after the round, whereafter they will enter the official registration and book-entry affiliation (Note. It will take some time until the shares are registered and cleared to the electronic book-entry securities system).
Medicortex Finland Oyj (Plc)
Itäinen Pitkäkatu 4 B, 4th floor
Tel. +358 (0)400 870 366
* illustration only
Note: This information may not be published or distributed directly or indirectly in the United States, Australia, Canada, Hong Kong, South Africa, Singapore, New Zealand, Japan or in any other country where disclosure or dissemination would be unlawful.
Investments always carry risks - Invest responsibly